/
/
Ready to Learn More About Myeloma From the Best Doctors Out There? Here's Your Chance! We're Hosting A Series Of Round Tables on High-Risk Disease. Salt Lake City Goes First on May 7, Discount Rates Available
Ready to Learn More About Myeloma From the Best Doctors Out There? Here's Your Chance! We're Hosting A Series Of Round Tables on High-Risk Disease. Salt Lake City Goes First on May 7, Discount Rates Available image
Ready to Learn More About Myeloma From the Best Doctors Out There? Here's Your Chance! We're Hosting A Series Of Round Tables on High-Risk Disease. Salt Lake City Goes First on May 7, Discount Rates Available
Posted Mar 29, 2016

The Myeloma Crowd is pleased to announce a new program to help patients and caregivers make better decisions and plans about treatment: Myeloma Crowd Round Tables on High-Risk Disease. These will be day-long patient education meetings featuring top myeloma experts.  They will be held in cities throughout the United States—six are planned in 2016—and focus on issues related to high-risk disease. Between 15-25% of newly diagnosed patients have high-risk disease.  And, as patients become refractory to treatments or relapse shortly after transplants or starting maintenance therapy, they move from low to high-risk categories.  In other words, the majority of myeloma patients will exhibit high-risk features during the course of their disease. Each meeting will feature patient-friendly presentations about high-risk issues including specific chromosomal translocations and deletions, genomics, treatment issues like drug combinations and transplants, and the latest updates on research and clinical trials.  Every meeting will reserve extensive time for attendees to ask questions. Despite the progress being made in treating myeloma, no standardized definition of high-risk disease exists; some individual institutions have developed their own criteria, but there is no consensus among experts as to what precisely determines when a patient has high-risk disease.  Consequently, there are no standard protocols for the treatment of high-risk disease, although some have long existed and continue to evolve in most diagnosed stages of myeloma. The Myeloma Crowd Round Tables on High-Risk Disease seek to help the myeloma community to better understand these issues and move the understanding of these issues forward to benefit researchers, clinicians and—most importantly—patients.

Salt Lake City, May 7, 2016

Register Today Registration cost is $25

St. Louis, June 18, 2016

Register Today Registration cost is $25    

The author Greg Brozeit

about the author
Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811